Home > Journals > Gazzetta Medica Italiana Archivio per le Scienze Mediche > Past Issues > Gazzetta Medica Italiana - Archivio per le Scienze Mediche 2022 March;181(3) > Gazzetta Medica Italiana - Archivio per le Scienze Mediche 2022 March;181(3):172-6

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

CASE REPORT   

Gazzetta Medica Italiana - Archivio per le Scienze Mediche 2022 March;181(3):172-6

DOI: 10.23736/S0393-3660.20.04383-1

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Extracorporeal photopheresis in elderly patient with refractory mycosis fungoides

Antonello SICA 1 , Paola VITIELLO 2, Caterina SAGNELLI 3, Evangelista SAGNELLI 3, Giuseppe ARGENZIANO 2, Teresa TROIANI 1, Beniamino CASALE 4, Maria MOTTOLA 5

1 Department of Precision Medicine, Luigi Vanvitelli University of Campania, Naples, Italy; 2 Dermatology Unit, Luigi Vanvitelli University of Campania, Naples, Italy; 3 Department of Mental and Physical Health and Preventive Medicine, Luigi Vanvitelli University of Campania, Naples, Italy; 4 Department of Pneumology and Tisiology, AORN Ospedali Dei Colli, Naples, Italy; 5 Department of Heart Surgery and Transplantations, AORN Ospedali Dei Colli, Naples, Italy



BACKGROUND: Mycosis fungoides (MF) are rare cutaneous T-cell lymphomas with an indolent long-term clinical course in elderly patients. The more advanced stages of the illness may require systemic chemotherapy, extracorporeal photophoresis (ECP) and/or radiotherapy (including total body irradiation), denileukin diftitox, alemtuzumab and allogeneic stem cell transplantation. ECP is unique among these treatment modalities because it specifically induces an immune reaction directed against T cells.
METHODS: We report a case of a 61-year-old Caucasian woman with MF, non-responder to the first line treatment, treated with ECP with very well fastly response.
RESULTS: The treatment was evaluated with several parameters and among these, the one that gave the greatest correspondence to the clinical course of the illness was IL2.
CONCLUSIONS: ECP is a tolerable treatment and free of the side effects that may occur with conventional chemotherapy, therefore it should be used more frequently, especially in MF, where it is frequent that patients have to undergo multiple treatment lines for indolent trend that characterizes it.


KEY WORDS: Photopheresis; Mycosis fungoides; Lymphoma, T-cell, cutaneous

top of page